Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.. Caris Life Sciences has now raised $1.86 billion in capital since 2018.

Caris Life Sciences CEO and chairman David Dean Halbert, celebrates the company's initial public offering and listing on the Nasdaq exchange by ringing the opening bell on Wednesday, June 18, 2025.